OM:SECT B

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Sectra AB (publ) provides IT systems for managing medical images and patient information related to diagnostic imaging. More Details

Rewards

Earnings are forecast to grow 12.67% per year

Earnings have grown 14.5% per year over the past 5 years

Risk Analysis

No risks detected for SECT B from our risk checks.


Snowflake Analysis

Flawless balance sheet with solid track record.


Similar Companies

Share Price & News

How has Sectra's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: SECT B has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

-2.9%

SECT B

-1.4%

SE Medical Equipment

-2.4%

SE Market


1 Year Return

73.2%

SECT B

19.0%

SE Medical Equipment

16.8%

SE Market

Return vs Industry: SECT B exceeded the Swedish Medical Equipment industry which returned 18.5% over the past year.

Return vs Market: SECT B exceeded the Swedish Market which returned 16.4% over the past year.


Shareholder returns

SECT BIndustryMarket
7 Day-2.9%-1.4%-2.4%
30 Day-8.8%0.8%1.4%
90 Day7.8%15.6%11.8%
1 Year73.2%73.2%20.9%19.0%18.9%16.8%
3 Year292.4%292.4%71.4%51.1%31.9%17.8%
5 Year480.6%480.6%100.4%66.5%69.4%36.4%

Price Volatility Vs. Market

How volatile is Sectra's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Sectra undervalued compared to its fair value and its price relative to the market?

95.07x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: SECT B (SEK569) is trading above our estimate of fair value (SEK107.47)

Significantly Below Fair Value: SECT B is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: SECT B is poor value based on its PE Ratio (95.1x) compared to the SE Medical Equipment industry average (34x).

PE vs Market: SECT B is poor value based on its PE Ratio (95.1x) compared to the Swedish market (22.1x).


Price to Earnings Growth Ratio

PEG Ratio: SECT B is poor value based on its PEG Ratio (7.5x)


Price to Book Ratio

PB vs Industry: SECT B is overvalued based on its PB Ratio (27.2x) compared to the SE Medical Equipment industry average (4.8x).


Next Steps

Future Growth

How is Sectra forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

12.7%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: SECT B's forecast earnings growth (12.7% per year) is above the savings rate (0.5%).

Earnings vs Market: SECT B's earnings (12.7% per year) are forecast to grow slower than the Swedish market (14.7% per year).

High Growth Earnings: SECT B's earnings are forecast to grow, but not significantly.

Revenue vs Market: SECT B's revenue (11.6% per year) is forecast to grow faster than the Swedish market (3.8% per year).

High Growth Revenue: SECT B's revenue (11.6% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: SECT B's Return on Equity is forecast to be high in 3 years time (30%)


Next Steps

Past Performance

How has Sectra performed over the past 5 years?

14.5%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: SECT B has high quality earnings.

Growing Profit Margin: SECT B's current net profit margins (13.8%) are higher than last year (13.2%).


Past Earnings Growth Analysis

Earnings Trend: SECT B's earnings have grown by 14.5% per year over the past 5 years.

Accelerating Growth: SECT B's earnings growth over the past year (17.2%) exceeds its 5-year average (14.5% per year).

Earnings vs Industry: SECT B earnings growth over the past year (17.2%) underperformed the Medical Equipment industry 17.2%.


Return on Equity

High ROE: SECT B's Return on Equity (28.5%) is considered high.


Next Steps

Financial Health

How is Sectra's financial position?


Financial Position Analysis

Short Term Liabilities: SECT B's short term assets (SEK913.0M) exceed its short term liabilities (SEK506.2M).

Long Term Liabilities: SECT B's short term assets (SEK913.0M) exceed its long term liabilities (SEK76.0M).


Debt to Equity History and Analysis

Debt Level: SECT B's debt to equity ratio (0.4%) is considered satisfactory.

Reducing Debt: SECT B's debt to equity ratio has reduced from 5.8% to 0.4% over the past 5 years.

Debt Coverage: SECT B's debt is well covered by operating cash flow (13885.2%).

Interest Coverage: SECT B earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is Sectra current dividend yield, its reliability and sustainability?

0.94%

Forecast Dividend Yield


Dividend Yield vs Market

Notable Dividend: Unable to evaluate SECT B's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate SECT B's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if SECT B's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if SECT B's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: SECT B is not paying a notable dividend for the Swedish market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of SECT B's dividend in 3 years as they are not forecast to pay a notable one for the Swedish market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

7.8yrs

Average management tenure


CEO

Torbjörn Kronander (63 yo)

7.83yrs

Tenure

kr4,409,000

Compensation

Dr. Torbjörn Kronander, Ph.D., MBA, has been the Chief Executive Officer and President of Sectra Aktiebolag (publ) since November 1, 2012 and also serves as its Director since 1988. Dr. Kronander has also ...


CEO Compensation Analysis

Compensation vs Market: Torbjörn's total compensation ($USD482.77K) is below average for companies of similar size in the Swedish market ($USD932.92K).

Compensation vs Earnings: Torbjörn's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Torbjörn Kronander
President7.83yrskr4.41m8.06%
SEK 1.8b
Robert Forchheimer
no datano data3.58%
SEK 785.4m
Viiveke Fåk
no datano data3.4%
SEK 745.3m
Ingemar Ingemarsson
no datano data0.71%
SEK 155.0m
Mats Franzén
Chief Financial Officer4.67yrsno data0.032%
SEK 7.1m
Fredrik Gustavsson
Chief Technology Officerno datano datano data
Per Andersnäs
Chief Information Officerno datano data0.0012%
SEK 256.3k
Helena Pettersson
Chief Investor Relations Officerno datano datano data
Lisa Everhill
Chief People & Brand Officerno datano data0.0069%
SEK 1.5m
Simo Pykälistö
President of Secure Communications Operating Area & Executive VP7.75yrsno data0.087%
SEK 19.1m
Marie Tragardh
President of Imaging IT Solutions Business Area7.75yrsno data0.13%
SEK 29.5m
Petter Østbye
Head of Medical Information Technology Operations - Scandinaviano datano datano data

7.8yrs

Average Tenure

51yo

Average Age

Experienced Management: SECT B's management team is seasoned and experienced (7.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Torbjörn Kronander
President7.83yrskr4.41m8.06%
SEK 1.8b
Jan-Olof Brüer
Chairman of the Board2yrskr450.00k7.99%
SEK 1.7b
Christer Nilsson
Independent Director12.67yrskr325.00k0.019%
SEK 4.2m
Anders Persson
Independent Director16.67yrskr275.00k0.11%
SEK 23.0m
Tomas Puusepp
Independent Director3.67yrskr225.00kno data
Birgitta Hagenfeldt
Independent Director2yrskr275.00k0.0052%
SEK 1.1m
Filip Klintenstedt
Deputy Employee Representative Board Member1.67yrsno data0.0032%
SEK 712.1k
Andreas Örnéus
Deputy Employee Representative Board Member2.67yrsno datano data
Jonas Yngvesson
Independent Director1yrkr150.00k0.053%
SEK 11.7m
Fredrik Robertsson
Directorno datano datano data

2.7yrs

Average Tenure

63yo

Average Age

Experienced Board: SECT B's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Sectra AB (publ)'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Sectra AB (publ)
  • Ticker: SECT B
  • Exchange: OM
  • Founded: 1978
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: kr21.910b
  • Shares outstanding: 38.51m
  • Website: https://www.sectra.com

Number of Employees


Location

  • Sectra AB (publ)
  • Teknikringen 20
  • Linköping
  • Östergötland County
  • 583 30
  • Sweden

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
SECT BOM (OMX Nordic Exchange Stockholm)YesSeries B SharesSESEKMar 1999
0A0LLSE (London Stock Exchange)YesSeries B SharesGBSEKMar 1999
SECTBSBATS-CHIXE (BATS 'Chi-X Europe')YesSeries B SharesGBSEKMar 1999

Biography

Sectra AB (publ) provides IT systems for managing medical images and patient information related to diagnostic imaging. The company’s Imaging IT Solutions segment develops and sells medical IT systems and ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/27 04:06
End of Day Share Price2020/09/25 00:00
Earnings2020/07/31
Annual Earnings2020/04/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.